4-Aminomethyltetrahydropyran: A Key Building Block in Pharmaceutical Synthesis
NINGBO INNO PHARMCHEM CO.,LTD. is a premier provider of high-quality chemicals essential for cutting-edge research and manufacturing. Among our specialized offerings, 4-Aminomethyltetrahydropyran (CAS 130290-79-8) plays a significant role as a versatile building block in pharmaceutical synthesis.
With a purity of 98.0%, 4-Aminomethyltetrahydropyran is a colorless liquid that serves as a critical intermediate for various complex organic syntheses. Its molecular structure, featuring both an amine group and a tetrahydropyran ring, makes it highly valuable for constructing molecules with specific pharmacological properties. Researchers frequently seek to buy 4-Aminomethyltetrahydropyran to incorporate these desirable structural elements into their drug candidates.
The compound's primary application lies in its use as a reagent in the discovery and development of innovative pharmaceuticals. It is particularly noted for its role in the synthesis of CC214-2, a compound that selectively inhibits mTOR kinase. The mTOR pathway is a key regulator of cell growth, and its inhibition is a promising strategy in cancer therapy. Similarly, 4-Aminomethyltetrahydropyran is employed in the creation of pyrazoloquinolines, which are investigated as PDE10A inhibitors for treating conditions like schizophrenia.
The reliability of chemical building blocks is paramount in pharmaceutical research, where precision and reproducibility are non-negotiable. NINGBO INNO PHARMCHEM CO.,LTD. ensures that our supply of 4-Aminomethyltetrahydropyran meets the stringent demands of the industry, supporting critical processes such as mTOR kinase inhibitor development and PDE10A inhibitor synthesis.
For companies involved in drug discovery, securing a consistent and high-quality supply of essential chemical intermediates for drug discovery is vital for maintaining project momentum. Understanding the specific requirements for a 4-Aminomethyltetrahydropyran pharmaceutical reagent, we focus on delivering products that facilitate efficient and successful research outcomes.
In essence, 4-Aminomethyltetrahydropyran is a key enabler of pharmaceutical innovation. Its incorporation into advanced synthetic pathways allows researchers to explore new therapeutic avenues and develop treatments for challenging diseases. NINGBO INNO PHARMCHEM CO.,LTD. is proud to support these critical endeavors by providing this essential chemical.
Perspectives & Insights
Nano Explorer 01
“It is particularly noted for its role in the synthesis of CC214-2, a compound that selectively inhibits mTOR kinase.”
Data Catalyst One
“The mTOR pathway is a key regulator of cell growth, and its inhibition is a promising strategy in cancer therapy.”
Chem Thinker Labs
“Similarly, 4-Aminomethyltetrahydropyran is employed in the creation of pyrazoloquinolines, which are investigated as PDE10A inhibitors for treating conditions like schizophrenia.”